DNA damage induced by oridonin involves cell cycle arrest at G2/M phase in human MCF-7 cells

Wspolczesna Onkologia

Volumn 17, Issue 1, 2013, Pages 38-44

  Zhang, Tao ^a,b   Tan, Yan ^a,c   Zhao, Rui ^d   Liu, Zhaoyang ^b  

^a JILIN UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

^c People's Hospital of Jilin Province Tumor Biological Treatment Research Center Changchun   (China)

^d HEILONGJIANG AUGUST FIRST LAND RECLAMATION UNIVERSITY   (China)

Author keywords

Apoptosis; ATM; Cell cycle; CHK2; Oridonin; P53

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; HISTONE H2AX; ORIDONIN; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL DAMAGE; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CYTOTOXICITY; DNA DAMAGE; DNA FRAGMENTATION; DRUG STRUCTURE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; PROTEIN EXPRESSION;

EID: 84876246463     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2013.33772     Document Type: Article

References (24)

1. Perera NM, Gui GP. Multi-ethnic differences in breast cancer: Current concepts and future directions. Int J Cancer 2003; 106: 463-7.
2. Schwartsmann G, Ratain MJ, Cragg GM, et al. Anticancer drug discovery and development throughout the world. J Clin Oncol 2002; 20 (18 Suppl): 47S-59S.
3. Wang H, Ye Y, Chui JH, Zhu GY, Li YW, Fong DW, Yu ZL. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells. Oncol Rep 2010; 24: 647-51.
4. Liu YQ, You S, Tashiro S, Onodera S, Ikejima T. Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signalregulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells. J Pharmacol Sci 2005; 98: 361-71.
5. Bai N, He K, Zhou Z, et al. Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines. Planta Med 2010; 76: 140-5.
6. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-kap-paB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005; 337: 224-31.
7. Ciciarello M, Mangiacasale R, Casenghi M, Zaira Limongi M, D'Angelo M, Soddu S, Lavia P, Cundari E. p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle. J Biol Chem 2001; 276: 19205-13.
8. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 2002; 12: 162-9.
9. Fernandez-Capetillo O, Chen HT, Celeste A, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 2002; 4: 993-7.
10. Celeste A, Difilippantonio S, Difilippantonio MJ, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003; 114: 371-83.
11. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001; 15: 2177-96.
12. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997; 277: 1501-5.
13. Wu H, Guo H, Zhao R. Effect of Lycium barbarum polysaccharide on the improvement of antioxidant ability and DNA damage in NIDDM rats. Yakugaku Zasshi 2006; 126: 365-71.
14. Stracker TH, Usui T, Petrini JH. Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) 2009; 8: 1047-54.
15. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39-85.
16. Reinhardt HC, Yaffe MB. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 2009; 21: 245-55.
17. Bartkova J, Horejsí Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864-70.
18. Bucher N, Britten CD. G2 checkpoint abrogation and checkpoint kina se-1 targeting in the treatment of cancer. Br J Cancer 2008; 98: 523-8.
19. Ociepa T, Maloney E, Kamieńska E, et al. Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia. Pol J Pathol 2010; 61: 199-205.
20. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155-68.
21. Liu Q, Guntuku S, Cui XS, et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14: 1448-59.
22. Fernandez-Capetillo O, Chen HT, Celeste A, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 2002; 4: 993-7.
23. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
24. Wahl GM, Carr AM. The evolution of diverse biological responses to DNA damage: Insights from yeast and p53. Nat Cell Biol 2001; 3: E277-86.